Abstract
This groundbreaking study delves into the transformative potential of Intermittent Normobaric Hypoxia Therapy (INHT) in a targeted cohort of 50 young adult COVID-19 survivors, aged 18 to 24 years. Through comprehensive pre- and post-INHT spirometry assessments, our research uncovers the nuanced respiratory benefits of this innovative therapy. The results showcase significant improvements in key spirometry parameters, emphasizing INHT's pivotal role in restoring lung function and fostering holistic respiratory well-being post-COVID-19
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
